Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression
- PMID: 24526468
- DOI: 10.1007/s12032-014-0884-9
Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression
Abstract
Patients with chronic pancreatitis with local inflammation have high risk for pancreatic cancer. The aim of this study was to examine the role of the inflammatory cells in the invasion of pancreatic cancer cells, focusing on the involvement of a disintegrin and metalloproteinase 8 (ADAM8) and matrix metalloproteinase 9 (MMP9) proteins. ADAM8 expression is associated with worse survival of pancreatic cancer patients. Monocytes from healthy donors were differentiated into macrophages. Pancreatic adenocarcinoma cells were cultured either alone or with differentiated macrophages. The cancer cell migration rate in Matrigel was measured by imaging fluorescently stained cells for 24 h. After invasion, cells were sorted into CD14 positive/negative macrophages and cancer cells with magnetic separation. The expression of ADAM8 and MMP9 was measured by the real-time PCR. Protein-level expression of ADAM8 and MMP9 was analyzed by Western blotting. In two series, siRNA technique was used to reduce either ADAM8 or MMP9 expression in the cancer cells. The coculture with macrophages increased cancer cell migration rate in Matrigel, and increased ADAM8 and MMP9 mRNA expression and protein level in the cancer cells. Reduction of ADAM8 expression with siRNA in the cancer cells decreased macrophage-induced migration rate of the cancer cells from 11.7±0.3 μm/h to 9.0±0.2 μm/h (p<0.01), and reduction of MMP9 expression decreased the migration rate to 10.1±0.2 μm/h (p<0.01). Anti-inflammatory macrophages increase pancreatic cancer cell migration rate in basement membrane matrix by inducing ADAM8 and MMP9 expression in cancer cells, thereby possibly enhancing the invasiveness of cancer.
Similar articles
-
ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.J Cell Mol Med. 2007 Sep-Oct;11(5):1162-74. doi: 10.1111/j.1582-4934.2007.00082.x. J Cell Mol Med. 2007. PMID: 17979891 Free PMC article.
-
Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.Pharmacol Rep. 2020 Apr;72(2):418-426. doi: 10.1007/s43440-019-00015-y. Epub 2019 Dec 20. Pharmacol Rep. 2020. PMID: 32048249
-
ADAM8 as a drug target in pancreatic cancer.Nat Commun. 2015 Jan 28;6:6175. doi: 10.1038/ncomms7175. Nat Commun. 2015. PMID: 25629724 Free PMC article.
-
ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.Clin Sci (Lond). 2019 Jan 11;133(1):83-99. doi: 10.1042/CS20180906. Print 2019 Jan 15. Clin Sci (Lond). 2019. PMID: 30635388 Review.
-
A jack of all trades - ADAM8 as a signaling hub in inflammation and cancer.FEBS J. 2024 Sep;291(18):3989-4008. doi: 10.1111/febs.17034. Epub 2023 Dec 22. FEBS J. 2024. PMID: 38097912 Review.
Cited by
-
Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Expert Opin Ther Targets. 2016;20(3):341-59. doi: 10.1517/14728222.2016.1094057. Epub 2015 Oct 6. Expert Opin Ther Targets. 2016. PMID: 26439702 Free PMC article. Review.
-
Increasing the Inflammatory Competence of Macrophages with IL-6 or with Combination of IL-4 and LPS Restrains the Invasiveness of Pancreatic Cancer Cells.J Cancer. 2016 Jan 1;7(1):42-9. doi: 10.7150/jca.12923. eCollection 2016. J Cancer. 2016. PMID: 26722359 Free PMC article.
-
Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.Diabetes Metab Syndr Obes. 2020 Feb 19;13:463-476. doi: 10.2147/DMSO.S235011. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32110079 Free PMC article.
-
Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems.Sci Rep. 2016 Jul 22;6:30110. doi: 10.1038/srep30110. Sci Rep. 2016. PMID: 27443190 Free PMC article.
-
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?Cancers (Basel). 2023 Jan 26;15(3):768. doi: 10.3390/cancers15030768. Cancers (Basel). 2023. PMID: 36765726 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous